"En el Centro Integral de Reumatología, S.A. de C.V. (CIRSA), realizamos actividades de Investigación Clínica con especialidad en Enfermedades Reumatológicas. Contamos con más de 20 años de experiencia en la realización de ensayos clínicos, aportando a nuestros pacientes bienestar, satisfacción y confianza."

During the past decade, Centro Integral en Reumatologia SA de CV conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 13 clinical trials were completed, i.e. on average, 68.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Integral en Reumatologia SA de CV" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integral en Reumatologia SA de CV" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Integral en Reumatologia SA de CV" are "Systemic Lupus Erythematosus" (6 trials), "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Centro Integral en Reumatologia SA de CV" in a lesser frequency.

Most popular intervention types in "Centro Integral en Reumatologia SA de CV" are "Drug" (22 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Baricitinib" (3 trials), "Adalimumab" (2 trials), "Etrolizumab" (2 trials) and "Methotrexate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Integral en Reumatologia SA de CV" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Centro Integral en Reumatologia SA de CV". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Centro Integral en Reumatologia SA de CV, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Integral en Reumatologia SA de CV, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".